Day 1
Monday, April 13, 2026
Course Welcome and Overview
Lynette Sholl; Valentina Nardi; Alanna Church
8:30-8:40 am
Integrated Molecular Oncology in 2026: Trends and Tools for gene fusion detection
Anthony Iafrate
8:40-9:10 am
End-to-end process to accelerating treatment initiation with next-day NGS
Charlotte Wang
9:10-9:40 am
Translation of Molecular to Immunohistochemistry
Lynette Sholl
9:40-10:10 am
Break
10:10-10:20 am
Informatics architecture
Matthew Lebo
10:20-10:50 am
NGS Pipelines Demystified: Practical Bioinformatics
Guruprasad Ananda
10:50-11:20 am
Tumor Mutation Burden, MSI, and HRD
Jonathan Nowak
11:20-11:50 am
Indel detection
Lauren Choate
11:50 am-12:20 pm
Lunch Break
12:20-1:20 pm
Viral sequence detection and other signatures
Mark Sabbagh
1:20-1:50 pm
Gene Fusion Detection and Interpretation by RNA-based NGS: a Practical, Cased-based Approach
Adam Fisch
1:50-2:20 pm
Additional informatics analyses
Harrison Tsai
2:20-2:50 pm
Oncogenicity interpretation of gene fusions detected by RNA-based NGS
Valentina Nardi
2:50-3:20 pm
Break
3:20-3:30 pm
Applications of Long-Read Sequencing for Cancer Diagnostics
Gabriel Griffin
3:30-4:00 pm
Liquid Biopsy and ctDNA: Technical and Clinical Perspectives
Alanna Church; David Shulman
4:00-4:30 pm
Panel Discussion: Tissue vs Liquid Biopsy
Lynette Sholl; Long Le; Alanna Church
4:30-5:00 pm
Day 2
Tuesday, April 14, 2026
Sarcoma and Fusion Testing
Adrian Mariño Enriquez
8:30-9:00 am
Molecular Diagnostics for GYN Tumors
Zehra Ordulu
9:00-9:30 am
Molecular Diagnostics for Pediatric Tumors
Alanna Church
9:30-10:00 am
Lung Tumor Testing
Igor Odintsov
10:00-10:30 am
Break
10:30-10:40 am
Copy Number Variation via NGS and Microarray
Alexander Neil; Laura Sack
10:40-11:20 am
Cytogenomics: technical focus
Scott Ryall
11:20-11:50 am
Cytogenomics: clinical focus
Philip Michaels
11:50 am-12:20 pm
Gliomas and Methylation Profiling
David Meredith
12:20-12:50 pm
Lunch Break
12:50-1:50 pm
Germline Testing in Oncology: What, When, and How (include confirmation)
Diana Mandelker
1:50-2:20 pm
Tumor-Normal Paired Sequencing: Clinical Impact
Jonathan Nowak
2:20-2:50 pm
Case Review: Pathology + Oncology Perspectives
Alanna Church; Suzanne Forrest
2:50-3:20 pm
Break
3:20-3:30 pm
Melanoma Molecular Pathology
Grant Fischer
3:30-4:00 pm
Molecular Diagnostics for Breast Cancer
Deborah Dillon
4:00-4:30 pm
Tumor Board Simulation: Real Case Review
Deborah Dillon; Seth Wander
4:30-5:00 pm
Day 3
Wednesday, April 15, 2026
Myeloid Neoplasms and MRD Testing
Habibe Kurt
8:30-9:00 am
Leukemia Molecular Diagnostics (B- and T-cell)
Marian Harris
9:00-9:30 am
Molecular Diagnostics and Lymphoma
Scott Rodig
9:30-10:00 am
Break
10:00-10:10 am
Pharmacogenomics in Oncology Management
Ann Moyer
10:10-10:40 am
GU Cancer Molecular Markers
Stephanie Siegmund
10:40-11:10 am
GI Cancer: Case-Based Applications
Esther Baranov
11:10-11:40 am
Thyroid Cancer and Salivary Tumor Genomics
Dora Dias-Santagata
11:40 am-12:10 pm
Lunch Break
12:10-1:10 pm
AI in Molecular Oncology
Melissa Zhao
1:10-1:40 pm
Interactive Workshop: Case Report Writing and Communication
Alanna Church
1:40-2:10 pm
The Power of Patient Partnership in Cancer Advocacy
Ann Graham
2:10-2:40 pm
Break
2:40-2:50 pm
Building a molecular profiling program
Laura MacConaill
2:50-3:20 pm
Regulatory and Reimbursement Essentials
Lauren Ritterhouse
3:20-3:50 pm
Lab Leadership and Challenges
Neal Lindeman
3:50-4:20 pm
Future Directions in Molecular Oncology
Lynette Sholl
4:20-4:50 pm